News
Despite advances, the roles of genetics and microenvironment in CLL are not fully understood, and curative treatments may hinge on a dual approach targeting both.
News-Medical.Net on MSN8d
CHAF1B drives lung squamous cell carcinoma progression by repressing SETD7CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...
AZoLifeSciences on MSN1d
Quantifying Breast Cancer Heterogeneity Through Single-Cell TranscriptomicsTumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental ...
CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...
Combination therapy of osimertinib and datopotamab deruxtecan shows promising efficacy in advanced NSCLC, warranting further ...
Tumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental ...
The FDA granted priority review to the combination of lurbinectedin and atezolizumab as a first-line maintenance therapy for ...
Epcoritamab Plus Chemoimmunotherapy Yields 87% Response Rate in R/R DLBCL; 65% Proceed to Transplant
Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback